Related Experiment Video
Updated: Jul 20, 2026
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Primary sclerosing cholangitis: summary of a workshop
Nicholas F LaRusso1, Benjamin L Shneider, Dennis Black
1Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Hepatology (Baltimore, Md.)
|August 31, 2006
Summary
Primary sclerosing cholangitis (PSC) is a rare liver disease affecting bile ducts, often requiring liver transplantation. Current therapies are limited, highlighting the need for further research into its causes and treatments.
Area of Science:
- Hepatology
- Autoimmune Diseases
- Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is a rare, progressive liver disease characterized by bile duct inflammation and fibrosis.
- It affects approximately 1 in 100,000 individuals annually, predominantly adults and males.
- PSC can lead to cirrhosis, liver failure, and necessitates liver transplantation in a significant proportion of patients.
Observation:
- Diagnosis relies on cholangiography showing bile duct strictures and dilatations, as biochemical and biopsy findings are suggestive but not definitive.
- The disease's natural history is variable, with average survival of 12-17 years.
- Despite being considered autoimmune, PSC exhibits atypical features and a strong genetic predisposition.
Findings:
- Standard ursodeoxycholic acid (UDCA) therapy improves biochemical markers but not histological or survival outcomes.
- Endoscopic dilatation offers benefits for high-grade strictures.
- Liver transplantation is effective for end-stage disease, though PSC recurrence post-transplant can occur.
Implications:
- Current therapeutic options for PSC are limited, with many innovative treatments showing scant benefit.
- Cholangiocarcinoma is a severe complication, difficult to diagnose early, with poor outcomes even post-transplantation.
- Significant opportunities exist for research into PSC's etiology, progression, and novel therapeutic strategies.
Related Concept Videos
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...